Stay updated on Pembrolizumab for Genomic Instability Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page
- ChecktodayChange DetectedThe page shows a revision update from v3.5.3 to v3.5.4, indicating a minor page update; no changes to the study data or eligibility criteria are indicated.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed revision/version number has been bumped from v3.5.2 to v3.5.3, reflecting a website release update rather than a change to the study content.SummaryDifference0.1%

- Check29 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check43 days agoChange DetectedStudy status updated to Active, not recruiting and results posted with related documentation (Results First Submitted/Posted) and dates. ORR outcome measure details are added to the Results section.SummaryDifference4%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a minor front-end update with no visible changes to the study details or related content.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.